Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Choksi LaboratoriesBOM:526546 57 Gross Margin % is 84.73% as of Mar. 2026, which is 2% below its 10-year median of 86.03. GuruFocus rates BOM:526546 with a GF Score™ of 57/100 and a GF Value™ of ₹97.92 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Choksi Laboratories ranks better than 89.69% on this metric.
Choksi Laboratories Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.3%.
The historical rank and industry rank for Choksi Laboratories's Gross Margin % or its related term are showing as below:
BOM:526546'
s Gross Margin % Range Over the Past 10 Years
Min: 82.8 Med: 86.03 Max: 90.58
Current: 82.98
During the past 13 years, the highestGross Margin % of Choksi Laboratories was 90.58%. The lowest was 82.80%. And the median was 86.03%.
BOM:526546's Gross Margin % is ranked better than 89.69% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 51.775
vs BOM:526546: 82.98
Choksi Laboratories had a gross margin of 84.73% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Choksi Laboratories was -1.30% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Choksi Laboratories had a gross margin of 84.73% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Choksi Laboratories Gross Margin % Related Terms
Choksi Laboratories Gross Margin % Historical Data
* Premium members only.
The historical data trend for Choksi Laboratories's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526546 vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Choksi Laboratories's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Choksi Laboratories Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Choksi Laboratories's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Choksi Laboratories's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Choksi Laboratories (BOM:526546) has a Gross Margin % of 84.73% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Choksi Laboratories and its competitors. This is near median its historical median of 86.03. Over the past decade, Choksi Laboratories' Gross Margin % has ranged from 82.80 to 90.58. According to the industry distribution chart, Choksi Laboratories ranks #20 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 10.3%.
Is Choksi Laboratories' Gross Margin % too high?
Choksi Laboratories' current Gross Margin % of 84.73% is near median its 10-year median of 86.03. Over the past 10 years, this metric has ranged from a low of 82.80 to a high of 90.58. The Medical Diagnostics & Research industry median Gross Margin % is 51.78. Choksi Laboratories' value of 84.73% is 63.7% above this industry median. Based on the distribution chart, Choksi Laboratories ranks #20 out of 194 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Choksi Laboratories has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Choksi Laboratories' Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Choksi Laboratories ranks #20 out of 194 companies for Gross Margin %. This places Choksi Laboratories in the top 10% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 51.78. Choksi Laboratories' value of 84.73% is 63.7% above this benchmark. Historically, Choksi Laboratories' own Gross Margin % has ranged from 82.80 to 90.58 over the past decade. While the company's 10-year median is 86.03 vs. the industry median of 51.78, Choksi Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.78, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Choksi Laboratories's current Gross Margin % of 84.73% is 63.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Choksi Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Choksi Laboratories's current Gross Margin % is 84.73%, which is near median its own 10-year median of 86.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Choksi Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Choksi Laboratories (BOM:526546) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹97.92, compared to a current price of ₹118.20 — trading 20.7% above its estimated fair value. The current Gross Margin % is 84.73%, which is near median its 10-year median of 86.03 and 63.7% above the Medical Diagnostics & Research industry median of 51.78. Choksi Laboratories' overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Choksi Laboratories (BOM:526546), the current Gross Margin % is 84.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Choksi Laboratories (BOM:526546) Overvalued in 2026?
Based on GuruFocus' analysis, Choksi Laboratories stock appears to be overvalued.
The current stock price of ₹118.20 is trading 20.7% above its estimated GF Value™ of ₹97.92.
GuruFocus considers Choksi Laboratories to be Modestly Overvalued.
Key valuation signals for BOM:526546:
Gross Margin %: 84.73% (near median its 10-year median of 86.03)
GF Value™: ₹97.92 vs. price of ₹118.20 (20.7% above fair value)
Industry Position: 63.7% above the Medical Diagnostics & Research median (#20 of 194)
No single metric tells the full story. See the BOM:526546 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Choksi Laboratories Ltd is an analysis and research company. The company provides contract testing and analytical services. The Company analyzes for its clients as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services.
57GF Score
Get the complete analysis for BOM:526546
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526546 has been successfully added to your 
